212 related articles for article (PubMed ID: 35563845)
1. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
Zhong C; Xie Z; Shen J; Jia Y; Duan S
Cells; 2022 May; 11(9):. PubMed ID: 35563845
[TBL] [Abstract][Full Text] [Related]
2. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
[TBL] [Abstract][Full Text] [Related]
3. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract][Full Text] [Related]
4. LINC00665 induces gastric cancer progression through activating Wnt signaling pathway.
Yang B; Bai Q; Chen H; Su K; Gao C
J Cell Biochem; 2020 Mar; 121(3):2268-2276. PubMed ID: 31736127
[TBL] [Abstract][Full Text] [Related]
5. LINC00665: A Promising Biomarker in Gastrointestinal Tumors.
Yuan M; Gu Y; Chen J; Jiang Y; Qian J; Cao S
Curr Mol Med; 2024; 24(1):51-59. PubMed ID: 36464865
[TBL] [Abstract][Full Text] [Related]
6. A Concise Review on Dysregulation of LINC00665 in Cancers.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Hajiesmaeili M
Cells; 2022 Nov; 11(22):. PubMed ID: 36429005
[TBL] [Abstract][Full Text] [Related]
7. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract][Full Text] [Related]
8. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double-Stranded RNA-Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma.
Ding J; Zhao J; Huan L; Liu Y; Qiao Y; Wang Z; Chen Z; Huang S; Zhao Y; He X
Hepatology; 2020 Nov; 72(5):1666-1681. PubMed ID: 32083756
[TBL] [Abstract][Full Text] [Related]
11. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Wang H; Wang L; Zhang S; Xu Z; Zhang G
Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
14. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
15. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).
Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Roles of LINC00665 in Human Cancers.
Zhu J; Zhang Y; Chen X; Bian Y; Li J; Wang K
Front Cell Dev Biol; 2022; 10():839177. PubMed ID: 35356290
[TBL] [Abstract][Full Text] [Related]
18. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.
Li YR; Zong RQ; Zhang HY; Meng XY; Wu FX
Front Genet; 2022; 13():861096. PubMed ID: 35350239
[No Abstract] [Full Text] [Related]
19. LINC00665 promotes HeLa cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the WNT-CTNNB1/β‑catenin signaling pathway.
Xia L; Chen YX; Lian JB
Sheng Li Xue Bao; 2021 Apr; 73(2):233-243. PubMed ID: 33903885
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
